To further address the roles of CRMP2 in CRC and DM comorbidity in vivo, CRC-DM disease models were generated by combining DIO with AOM/DSS treatment as described in Section 2.5 [24]. The gene discussed is DPYSL2; the disease is colorectal carcinoma.